Answers are grounded in this paper and cite their sources.
Due in large part to many landmark innovations in the care of the surgical patient, such as the use of anesthesia [1] and the development of the principles of antibiotic prophylaxis [2, 3], the number of surgical procedures performed annually has climbed steadily, with >24 million surgical procedures performed in 2001 in the United States alone [4]. Unfortunately, as surgical volume has increased and with the development of novel surgical procedures, the number of persons at risk of morbidity from surgical site infections (SSIs) has also increased. According to the most-recent estimates, 500,000 SSIs occur annually in the United States, leading to an estimated 3.7 million excess hospital days and >$1.6 billion in excess costs [5, 6]. A patient who develops an SSI while hospitalized has an -60% greater risk of being admitted to the intensive care unit, is >5 times more likely to be readmitted to the hospital within 30 days after discharge, and incurs an attributable extra hospital stay of 6.5 days, leading to a direct cost of an additional $3000/infection [7]. Attempts to reduce such morbidity have appropriately focused on the identification of specific risk factors for SSI. Such factors may be specific to single surgical types, such as the use of internal mammary arteries for coronary arterial bypass grafting [8, 9], but many are applicable to most surgical procedures. In general, these risk factors can be categorized into 2 groups: characteristics of the surgical patient and characteristics of the procedure itself (figure 1) [10, 11]. Some risk factors-in particular, patient characteristics such as altered immune
No takes yet. Share an insight, caveat, or question.
Talbot et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: